Search your stocks

Share

Profile

SUNPHARMASun Pharmaceutical Industries Ltd.

1662.6(+0.85%)

1W: +3.57%

1M: +1.01%

1Y: +1.19%

Financials

Charts

YoY Net Sales

Operating Margin

EPS Growth

Pros & Cons

POSITIVES

Revenue shows consistent growth, with a 5.5% increase from the previous quarter.
Net profit reached ₹3,037.33 crore, the highest in four quarters, indicating strong operational efficiency.
Operating profit margin improved to 23.44%, reflecting better cost management.

NEGATIVES

Revenue decreased by 2.3% compared to the previous quarter, indicating potential market challenges.
Net profit is projected to decline in the next quarter, possibly due to seasonal effects.
Other income showed volatility, affecting overall profitability trends.

Quarterly Results Data

Field	Trend	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue		12,192.40	12,380.70	11,982.90	12,652.80	13,291.40	13,675.50	12,958.80	13,851.40
Expenses		9,695.14	9,685.30	9,671.68	9,761.80	10,175.60	10,348.50	10,246.90	10,554.10
Operating Profit		2,497.26	2,695.40	2,311.22	2,891	3,115.80	3,327	2,711.90	3,297.30
Other Income		293.61	374.76	605.94	532.55	482.09	465.62	904.11	693.50
Interest		49.29	34.73	73.57	61.54	69.17	51.51	49.14	74.80
Depreciation		632.82	622.14	650.36	655.13	625.91	630.56	663.79	700.55
Profit Before Tax		2,775.20	2,992.86	2,807.67	3,412.76	3,604.54	3,471.84	3,247.64	3,163.02
Tax		390.10	432.32	148.93	552.25	567.21	558.86	1,093.71	870.15
Net Profit		2,385.10	2,560.54	2,658.74	2,860.51	3,037.33	2,912.98	2,153.93	2,292.87
Eps in Rs		9.90	10.50	11.10	11.80	12.70	12.10	9	9.50